Sana Biotechnology
SANA
SANA
155 hedge funds and large institutions have $639M invested in Sana Biotechnology in 2024 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 41 increasing their positions, 45 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
9% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 45
21% less capital invested
Capital invested by funds: $810M → $639M (-$171M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
155
Holding in Top 10
3
Calls
$9.77M
Puts
$6.42M
Top Buyers
| 1 | +$18.5M | |
| 2 | +$3.21M | |
| 3 | +$2.5M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.31M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.27M |
Top Sellers
| 1 | -$4.93M | |
| 2 | -$1.22M | |
| 3 | -$1.11M | |
| 4 |
Citigroup
New York
|
-$1.04M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.01M |